Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Advancements in Lung Cancer Diagnosis: Innovations and Implications for Early Detection and Personalized Management

Laura Muccillo*

Lung cancer is a devastating disease with high mortality rates worldwide. Early diagnosis plays a critical role in improving patient outcomes and enhancing treatment efficacy. This abstract provides a concise overview of the recent advancements in lung cancer diagnosis, focusing on innovative modalities and biomarkers that have revolutionized early detection and personalized management. The abstract highlights the significance of imaging technologies, molecular biomarkers, and minimally invasive procedures in the early identification of lung cancer. Additionally, it discusses the emerging role of artificial intelligence in refining diagnostic accuracy and the potential future directions in lung cancer diagnosis. This comprehensive review aims to provide healthcare professionals and researchers with a current understanding of the state-of-the-art techniques available to optimize lung cancer diagnosis and treatment planning.